MRI and Probe Eye-Drops Reveal Gene in Action in Brain

Existing techniques involve a risky, invasive, and relatively slow process of penetrating the skull to extract tissue samples and then examining those samples in a laboratory. "We hope our study provides a tool for better treatments of neurologic diseases, diagnosis, prognosis during therapy, and improved delivery of therapeutic agents to the brain,” said Dr. Philip Liu of Harvard University (Cambridge, MA, USA), one of the researchers involved in the study. Dr. Liu also said that more research is necessary to determine precisely how these gene probes reach brain tissue.

In this study, published in the April 2008 issue of The FASEB Journal, the investigators linked a comparatively common MRI probe (superparamagnetic iron oxide nanoparticles) to a short DNA sequence that binds to proteins in cells responsible for brain tissue repair (glia and astrocytes). Then, they used the eye-drops on mice with conditions that cause "leaks” in the blood-brain barrier. When the animals' brains were scanned using MRI, brain repair activity was visible. Glia and astrocytes help repair brain and nerve tissue, and have a role in numerous diseases and disorders that cause at least microscopic openings in the blood-brain barrier, including traumatic brain injury, multiple sclerosis, stroke, cardiac arrest, and glioma, among others. Furthermore, the researchers believe that the probes may also help diagnose thinning of vascular walls in brains, which occurs as Alzheimer's disease progresses.

"When people are sick, the last thing you want to do is puncture their skulls for a biopsy,” said Gerald Weissmann, M.D., editor-in-chief of The FASEB Journal, "but sometimes this is unavoidable. These probes of genes in action go a long way toward ushering in an age where extracting brain tissue to identify a disease will seem as crude as when doctors measured skulls to diagnose a mental disease.”


Related Links:
Harvard University